114 related articles for article (PubMed ID: 16954806)
1. The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease.
Ferrante M; Pierik M; Henckaerts L; Joossens M; Claes K; Van Schuerbeek N; Vlietinck R; Rutgeerts P; Van Assche G; Vermeire S
Inflamm Bowel Dis; 2006 Sep; 12(9):870-8. PubMed ID: 16954806
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor in inflammatory bowel disease.
Kapsoritakis A; Sfiridaki A; Maltezos E; Simopoulos K; Giatromanolaki A; Sivridis E; Koukourakis MI
Int J Colorectal Dis; 2003 Sep; 18(5):418-22. PubMed ID: 12761641
[TBL] [Abstract][Full Text] [Related]
3. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease.
Eloranta JJ; Wenger C; Mwinyi J; Hiller C; Gubler C; Vavricka SR; Fried M; Kullak-Ublick GA;
Pharmacogenet Genomics; 2011 Sep; 21(9):559-64. PubMed ID: 21832969
[TBL] [Abstract][Full Text] [Related]
4. Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis.
Seo JS; Lee SS; Kim SI; Ryu WH; Sa KH; Kim SU; Han SW; Nam EJ; Park JY; Lee WK; Kim SY; Kang YM
Rheumatology (Oxford); 2005 Oct; 44(10):1299-302. PubMed ID: 16014410
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
Langsenlehner U; Wolf G; Langsenlehner T; Gerger A; Hofmann G; Clar H; Wascher TC; Paulweber B; Samonigg H; Krippl P; Renner W
Breast Cancer Res Treat; 2008 May; 109(2):297-304. PubMed ID: 17636397
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease.
D'Amato M; Bruce S; Bresso F; Zucchelli M; Ezer S; Pulkkinen V; Lindgren C; Astegiano M; Rizzetto M; Gionchetti P; Riegler G; Sostegni R; Daperno M; D'Alfonso S; Momigliano-Richiardi P; Torkvist L; Puolakkainen P; Lappalainen M; Paavola-Sakki P; Halme L; Farkkila M; Turunen U; Kontula K; Lofberg R; Pettersson S; Kere J
Gastroenterology; 2007 Sep; 133(3):808-17. PubMed ID: 17854592
[TBL] [Abstract][Full Text] [Related]
7. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease.
Ebrahimi Daryani N; Saghazadeh A; Moossavi S; Sadr M; Shahkarami S; Soltani S; Farhadi E; Rezaei N
Immunol Invest; 2017 Oct; 46(7):714-729. PubMed ID: 28872970
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
[TBL] [Abstract][Full Text] [Related]
10. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
Mittal RD; Manchanda PK; Bid HK; Ghoshal UC
J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
[TBL] [Abstract][Full Text] [Related]
11. Investigation of HLA-DPA1 genotypes as predictors of inflammatory bowel disease in the German, South African, and South Korean populations.
Lantermann A; Hampe J; Kim WH; Winter TA; Kidd M; Nagy M; Fölsch UR; Schreiber S
Int J Colorectal Dis; 2002 Jul; 17(4):238-44. PubMed ID: 12073072
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome.
Vural P; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Cil E; Karadağ B; Akgül C; Uysal M
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):57-60. PubMed ID: 19631445
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor gene polymorphisms and serum levels in Behçet's disease.
Kamoun M; Houman MH; Hamzaoui A; Hamzaoui K
Tissue Antigens; 2008 Dec; 72(6):581-7. PubMed ID: 19054372
[TBL] [Abstract][Full Text] [Related]
14. Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy.
Rapti E; Gazouli M; Legaki E; Karamanolis G; Thomas D; Marinos E; Papaconstantinou I
Genet Test Mol Biomarkers; 2015 Jun; 19(6):339-43. PubMed ID: 25918954
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; Wascher TC; Kapp KS
Eur J Cancer; 2008 Jul; 44(11):1572-6. PubMed ID: 18514506
[TBL] [Abstract][Full Text] [Related]
17. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor gene polymorphisms in North Indian patients with end stage renal disease.
Prakash S; Prasad N; Sharma RK; Faridi RM; Agrawal S
Cytokine; 2012 May; 58(2):261-6. PubMed ID: 22370607
[TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
20. Association of psoriasis with the VEGF gene polymorphism in the northern Polish population.
Zablotna M; Sobjanek M; Nedoszytko B; Lange M; Kozicka D; Glen J; Roszkiewicz J
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):319-23. PubMed ID: 22176586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
